Experts in treating interstitial lung disease
Our entire team at the Interstitial Lung Disease (ILD) clinic is dedicated to improving the lives of our patients with ILD through patient care, education and research.
Our multidisciplinary team combines the skills of pulmonologists, rheumatologists, thoracic radiologists and thoracic pathologists, all of whom have specific expertise in ILD and work closely with subspecialists, including the lung transplant team.
A Pulmonary Fibrosis Foundation Care Center
UCHealth University of Colorado Hospital is designated as a Pulmonary Fibrosis (PF) Foundation Care Center network site.
PF Care Centers have the necessary resources and specialized staff to fully manage pulmonary fibrosis, and use a multidisciplinary approach to provide the most comprehensive patient care. Experts in pulmonology, rheumatology, radiology, pathology and nursing specializing in interstitial lung disease comprise the care team at each PF Care Center.
Our care approach
Interstitial lung diseases vary greatly, but all of them involve scarring and inflammation in the lung. Our collaborative team is here to treat all of those medical conditions. We offer a comprehensive and personalized approach to your care, including:
- Diagnosis.
- Prognosis.
- Genetic risk assessment.
- Treatment, including novel antifibrotic therapy.
- Symptom management.
- Clinical trials (testing of new therapies).
- Education and support resources.
- Pulmonary rehabilitation services.
- Communication with providers to ensure continuity of care.
- Lung transplantation through the only program in the state.
We also provide unique expertise in a broad range of ILD and related respiratory diseases, including:
- Automimmune-related ILD.
- Familial pulmonary fibrosis.
- Hypersensitivity pneumonitis.
- Idiopathic pulmonary fibrosis.
- Lymphangioleiomyomatosis.
- Organizing pneumonia.
- Rheumatoid arthritis-associated ILD.
- Sarcoidosis.
- Scleroderma.
Clinical trials
Patients with lung and respiratory conditions have the opportunity to enroll in clinical trials, which aim to improve treatment protocols and patient outcomes.